论文部分内容阅读
Bimatoprost (LUMIGAN) is a novel synthetic prostamide that potently lowers intraocular pressure in dogs, primates and humans. Bimatoprost is functionally and pharmacologically distinct from PGF2alpha, potently exhibits prostamide-like activities and works directly to lower IOP. In this series of studies, confocal fluorescence microscopy was employed to compare the effects of
Bimatoprost is a novel synthetic prostamide that potently lowers intraocular pressure in dogs, primates and humans. Bimatoprost is functionally and pharmacologically distinct from PGF2alpha, potently exhibited prostamide-like activities and works directly to lower IOP. In this series of studies, confocal fluorescence microscopy was employed to compare the effects of